Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
The main goal of this study is to see how the body breaks down an antifungal drug named
posaconazole in children with certain cancers, blood disorders, or transplantation of bone
marrow or similar blood cells. This study will also help us learn whether a child's age,
genetics, or disease affect how well the body breaks down posaconazole.